On December 9, 2019 Genmab A/S (Nasdaq: GMAB) reported that it will hold an R&D Update and 2019 ASH (Free ASH Whitepaper) Data Review Meeting , December 9, 2019 at 8:00 PM Eastern Time (2:00 AM CET / 1:00 AM GMT on 10 December) (Press release, Genmab, DEC 9, 2019, View Source [SID1234552118]). The event will take place in Orlando, Florida, and will also be webcast live and archived on the company’s website. The meeting will include presentations by independent experts on data from the Phase I/II DuoBody-CD3xCD20 (GEN3013) study as well as various daratumumab studies presented at the 61st Annual Meeting of the American Society of Hematology (ASH) (Free ASH Whitepaper). Genmab speakers will also discuss the company’s pipeline, progress and key goals for 2020.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The following cancer experts and Genmab staff will speak during the event:
Independent experts:
Dr. Meletios A. Dimopoulos, National and Kapodistrian University of Athens, School of Medicine
Dr. Pieternella Lugtenburg, Erasmus University Medical Center Rotterdam
·Dr. Saad Usmani, University of North Carolina at Chapel Hill, Levine Cancer Institute
Genmab:
Dr. Jan van de Winkel, President and CEO, Genmab
Dr. Esther Breij, Senior Director, Translational Research
The event will take place at the Hyatt Regency Orlando in Orlando, Florida, in Bayhill 17-18. Those wishing to attend in person may register on site.
The event can also be attended via webcast. To view this webcast visit: View Source Webcast viewers may submit questions during the Q&A portion of the live webcast via the webcast player. An archive of the webcast will be available on Genmab’s website. The webcast will be conducted in English.
This meeting is not an official program of the ASH (Free ASH Whitepaper) Annual Meeting.